Abstract:The human gastrointestinal tract consists of different regions, each characterized by a distinct physiology, anatomy, and microbial community. While the colonic microbiota has received a lot of attention in recent research projects, little is known about the small intestinal microbiota and its interactions with ingested compounds, primarily due to the inaccessibility of this region in vivo . This study therefore aimed to develop and validate a dynamic, long-term simulation of the ileal microbiota using the SHIME ® -technology. Essential parameters were identified and optimized from a screening experiment testing different inoculation strategies, nutritional media, and environmental parameters over an 18-day period. Subjecting a synthetic bacterial consortium to the selected conditions resulted in a stable microbiota that was representative in terms of abundance [8.81 ± 0.12 log (cells/ml)], composition and function. Indeed, the observed community mainly consisted of the genera Streptococcus, Veillonella, Enterococcus, Lactobacillus , and Clostridium (qPCR and 16S rRNA gene targeted Illumina sequencing), while nutrient administration boosted lactate production followed by cross-feeding interactions towards acetate and propionate. Furthermore, similarly as in vivo , bile salts were only partially deconjugated and only marginally converted into secondary bile salts. After confirming reproducibility of the small intestinal microbiota model, it was integrated into the established M-SHIME® where it further increased the compositional relevance of the colonic community. This long-term in vitro model provides a representative simulation of the ileal bacterial community, facilitating research of the ileum microbiota dynamics and activity when, for example, supplemented with microbial or diet components. Furthermore, integration of this present in vitro simulation increases the biological relevance of the current M-SHIME® technology.

Simulator of the Human Intestinal Microbial Ecosystem (SHIME®): Current Developments, Applications and Future Prospects

The Effect of Intrinsic Factors and Mechanisms in Shaping Human Gut Microbiota

Development of a reproducible small intestinal microbiota model and its integration into the SHIME®-system, a dynamic in vitro gut model

Artificial Gastrointestinal Models for Nutraceuticals Research—Achievements and Challenges: A Practical Review

Intestinal Models for Personalized Medicine: from Conventional Models to Microfluidic Primary Intestine-on-a-chip

CHANGES IN THE MICROBIOME OF A HUMAN AND IN THE SIMULATOR OF HUMAN INTESTINAL MICROBIAL ECOSYSTEM (SHIME®) IN RESPONSE TO A DIET AND PROBIOTIC SUPPLEMENTATION

Gut-on-chip: Recreating human intestine in vitro

In Vitro Human Gastrointestinal Tract Simulation Systems: A Panoramic Review

[Advances of gut-on-a-chip for exploring host-microbe interactions]

Advances in reconstructing intestinal functionalities in vitro: From two/three dimensional-cell culture platforms to human intestine-on-a-chip

Emerging microfluidic gut-on-a-chip systems for drug development

The Progress of Intestinal Epithelial Models from Cell Lines to Gut-On-Chip

Human Microphysiological Models of Intestinal Tissue and Gut Microbiome

Primary exploration of host–microorganism interaction and enteritis treatment with an embedded membrane microfluidic chip of the human intestinal–vascular microsystem

Organ-on-Chip Approaches for Intestinal 3D In Vitro Modeling

Intestine‐on‐a‐chip for Intestinal Disease Study and Pharmacological Research

Advances in in Vitro Fermentation Model of Gut Microbiota and Its Applications in Food

Intestinal Stem Cell-on-Chip to Study Human Host-Microbiota Interaction

A complex human gut microbiome cultured in an anaerobic intestine-on-a-chip